Early myocardial dysfunction in the diabetic heart: Current research and clinical applications

American Journal of Cardiology

Volumn 93, Issue 8 SUPPL. 1, 2004, Pages 17-20

  Scognamiglio, Roldano ^a   Avogaro, Angelo ^a   Negut, Christian ^a   Piccolotto, Roberto ^a   Vigili De Kreutzenberg, Saula ^a   Tiengo, Antonio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE; AMINO ACID; ASPARTIC ACID; CARDIAC MYOSIN; GLUTAMIC ACID; GLUTAMINE; STREPTOZOCIN;

ACUTE HEART INFARCTION; CARDIOMYOPATHY; CITRIC ACID CYCLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISOMETRIC EXERCISE; NITROGEN METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVASCULARIZATION; REVIEW; SUPPLEMENTATION;

EID: 1942452319     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.11.004     Document Type: Article

References (37)

1. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure the Framingham study. Am J Cardiol. 34:1974;29-34.
2. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population sixteen year follow-up study. Diabetes. 23:1974;105-111.
3. Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., Deedwania P.C., Ney D.E., Snavely D.B., Chang P.I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 349:1997;747-752.
4. Tahiliani A.G., McNeill J.H. Diabetes-induced abnormalities in the myocardium. Life Sci. 38:1986;959-974.
5. Fein F.S., Sonnenblick E.H. Diabetic cardiomyopathy. Prog Cardiovasc Dis. 27:1985;255-270.
6. Factor S.M., Minase T., Sonnenblick E.H. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 99:1980;446-458.
7. Jaffe A.S., Spadaro J.J., Schechtman K., Roberts R., Geltman E.M., Sobel B.E. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J. 108:1984;31-37.
8. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 91:1995;1659-1668.
9. Scognamiglio R., Avogaro A., Casara D., Crepaldi C., Marin M., Palisi M., Mingardi R., Erle G., Fasoli G., Dalla Volta S. Myocardial dysfunction and adrenergic cardiac innervations in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 31:1998;404-412.
10. Ganguly P.K., Pierce G.N., Dhalla K.S., Dhalla N.S. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol. 244:1983;E528-E535.
11. Pierce G.N., Dhalla N.S. Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol. 13:1981;1063-1069.
12. Penpargkul S., Schaible T., Yipintsoi T., Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res. 47:1980;911-921.
13. Pain V.M., Albertse E.C., Garlick P.J. Protein metabolism in skeletal muscle, diaphragm, and heart of diabetic rats. Am J Physiol. 245:1983;E604-E610.
14. Avogaro A., Nosadini R., Doria A., Fioretto P., Velussi M., Vigorito C., Sacca L., Toffolo G., Cobelli C., Trevisan R., et al. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol. 258:1990;E606-E618.
15. Barrett E.J., Schwartz R.G., Young L.H., Jacob R., Zaret B.L. Effect of chronic diabetes on myocardial fuel metabolism and insulin sensitivity. Diabetes. 37:1988;943-948.
16. Hoffer L.J. Are dietary protein requirements altered in diabetes mellitus? Can J Physiol Pharmacol. 71:1993;633-638.
17. Hoffer L.J. Protein consumption and diabetes mellitus an overview. J Nutr. 128:1998;321S-322S.
18. Mildenberger R.R., Bar Shlomo B., Druck M.N., Jablonsky G., Morch J.E., Hilton J.D., Kenshole A.B., Forbath N., McLaughlin P.R. Clinically unrecognized ventricular dysfunction in young diabetic patients. J Am Coll Cardiol. 4:1984;234-238.
19. Vered A., Battler A., Segal P., Liberman D., Yerushalmi Y., Berezin M., Neufeld H.N. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy). Am J Cardiol. 54:1984;633-637.
20. Zola B., Kahn J.K., Juni J.E., Vinik A.I. Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J Clin Endocrinol Metab. 63:1986;208-214.
21. Mustonen J.N., Uusitupa M.I., Tahvanainen K., Talwar S., Laakso M., Lansimies E., Kuikka J.T., Pyorala K. Impaired left ventricular systolic function during exercise in middle-aged insulin-dependent and noninsulin-dependent diabetic subjects without clinically evident cardiovascular disease. Am J Cardiol. 62:1988;1273-1279.
22. Arvan S., Singal K., Knapp R., Vagnucci A. Subclinical left ventricular abnormalities in young diabetics. Chest. 93:1988;1031-1034.
23. Scognamiglio R., Fasoli G., Ferri M., Nistri S., Miorelli M., Egloff C., Buja G., Fedele D., Dalla Volta S. Myocardial dysfunction and abnormal left ventricular exercise response in autonomic diabetic patients. Clin Cardiol. 18:1995;276-282.
24. Malhotra A. Cardiac contractile proteins in diabetic cardiomyopathy. Nagano M., Dhalla N.S. The Diabetic Heart: Selected Papers Presented at the International Symposium on the Diabetic Heart. 1991;281-290 Raven Press, New York.
25. Miyairi M., Kawashima O., Nagai M., Ohkubo T., Takeda N., Nagano M. Adaptable capacity under pacing overload in diabetic rat hearts. Nagano M., Takeda N., Dhalla N. The Adapted Heart. 1994;415-422 Raven Press, New York.
26. Sonnenblick E. Force-velocity relations in mammalian heart muscle. Am J Physiol. 202:1962;931-939.
27. Urschel C.W., Covell J.W., Sonnenblick E.H., Ross J. Jr, Braunwald E. Myocardial mechanics in aortic and mitral valvular regurgitation the concept of instantaneous impedance as a determinant of the performance of the intact heart. J Clin Invest. 47:1968;867-883.
28. Eckberg D.L., Gault J.H., Bouchard R.L., Karliner J.S., Ross J. Jr. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation. 47:1973;1252-1259.
29. Zile M.R., Gaasch W.H., Levine H.J. Left ventricular stress-dimension- shortening relations before and after correction of chronic aortic and mitral regurgitation. Am J Cardiol. 56:1985;99-105.
30. Scognamiglio R., Avogaro A., Vigili de Kreutzenberg S., Negut C., Palisi M., Bagolin E., Tiengo A. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. Diabetes. 51:2002;808-812.
31. Khogali S.E.O., Pringle S.D., Weryk B.V., Rennie M.J. Is glutamine beneficial in ischemic heart disease? Nutrition. 18:2002;123-126.
32. Langenberg C.J., Pietersen H.G., Geskes G., Wagenmakers A.J., Lange S.D., Schouten H.J., Soeters P.B. The effect of glutamate infusion on cardiac performance is independent of changes in metabolism in patients undergoing routine coronary artery bypass surgery. Clin Sci (Lond). 101:2001;573-580.
33. Khogali S.E., Harper A.A., Lyall J.A., Rennie M.J. Effects of L-glutamine on post-ischaemic cardiac function protection and rescue. J Mol Cell Cardiol. 30:1998;819-827.
34. Swan J.W., Anker S.D., Walton C., Godsland I.F., Clark A.L., Leyva F., Stevenson J.C., Coats A.J. Insulin resistance in chronic heart failure relation to severity and etiology of heart failure. J Am Coll Cardiol. 30:1997;527-532.
35. De Fronzo REF. Insulin actions in vivo: protein metabolism. In: Alberti KGMM, De Fronzo RA, Keen H, Zimmet PZ, eds. International Textbook of Diabetes Mellitus. Hoboken, NJ: John Wiley & Sons, 1992:467-511.
36. Rennie M.J., Bowtell J.L., Bruce M., Khogali S.E. Interaction between glutamine availability and metabolism of glycogen, tricarboxylic acid cycle intermediates and glutathione. J Nutr. 131:2001;2488S-2490S.
37. Shiono N., Rao V., Weisel R.D., Kawasaki M., Li R.K., Mickle D.A.G., Fedak P.W.M., Tumiati L.C., Ko L., Verma S. L-Arginine protects human heart cells from low-volume anoxia and reoxygenation. Am J Physiol Heart Circ Physiol. 282:2002;H805-H815.